Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Crofelemer
Sponsor: Sandra Swain
Collaborators: Lombardi Comprehensive Cancer Center|Medstar Health Research Institute|Genentech, Inc.|Napo Pharmaceuticals, Inc.